Effect of Nitric Oxide in Transthyretin-Related Amyloidosis
Mitsuharu Ueda(Kumamoto University), Masaki Otagiri(Sojo University), J Kim, Yukio Ando(Nagoya University Hospital), Yohei Misumi(Kumamoto University), Takaaki Akaike(Tohoku University), Masaaki Nakamura(National Institute for Minamata Disease), Yu Ishima(Kyoto Pharmaceutical University), Konen Obayashi, Wei Meng(Tongji Hospital), Taro Yamashita(Kanazawa University), Seiichiro Himeno(SHOWA Medical University), S Saito, S Shinrik
Cited by 0
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
|Journal of Molecular Biology|2005|1.9k
Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues
|Japanese Journal of Cancer Research|1998|463
Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis
|Proceedings of the National Academy of Sciences|1997|333
Comparison between Er:YAG Laser and Conventional Technique for Root Caries Treatment in vitro
|Journal of Dental Research|1998|329